FindTrial
Sign In

The expression of MrgX2 receptor in human peripheral blood detected by paper-based ELISA

A new paper-based ELISA approach for rapid, sensitive and quantitative detection of anaphylaxis related MrgX2

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034238
Enrollment
Unknown
Registered
2020-06-29
Start date
2020-06-28
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Case series:N/A

Sponsors

Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged 6-80 years old; (2) No other diseases in the near future; (3) Those who voluntarily participate in this project and can perform as required; (4) Those who have signed the informed consent and can complete it as required.

Exclusion criteria

Exclusion criteria: (1) Patients with clear indications of acute infection; (2) Patients who are unable to cooperate or cannot adhere to treatment and predict poor compliance; (3) Pregnant women and lactating women; (4) The patient is also participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
MrgX2 protein level;—

Countries

China

Contacts

Public ContactLiyun Kong

Xi'an Jiaotong University Health Science Center

kongly@xjtu.edu.cn+86 15702990201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026